Drug Shortage Report for SANDOZ MONTELUKAST

Last updated on 2020-05-25 History
Report ID 111166
Drug Identification Number 02358611
Brand name SANDOZ MONTELUKAST GRANULES
Common or Proper name Montelakast
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 4MG
Dosage form(s) GRANULES
Route of administration ORAL ORAL
Packaging size 300
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-04-03
Estimated end date 2020-06-12
Actual end date 2020-05-22
Shortage status Resolved
Updated date 2020-05-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-05-25 French Compare
v7 2020-05-25 English Compare
v6 2020-05-11 French Compare
v5 2020-05-11 English Compare
v4 2020-05-04 French Compare
v3 2020-05-04 English Compare
v2 2020-04-06 French Compare
v1 2020-04-06 English Compare

Showing 1 to 8 of 8